Genetics of COVID-19 Susceptibility and Manifestations

Plain-language summary

This observational study looked at the role of genetic factors in susceptibility to COVID-19 and how the illness shows up. To join, people had to be in the United States, aged 3 or older, with a positive test for SARS-CoV-2. It was conducted as a non-phase observational study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

National Human Genome Research Institute (NHGRI)

Start date

5/5/2020

Estimated completion

12/15/2024

Countries

United States

Related genes

Locations

• Bethesda, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* INCLUSION CRITERIA
* Cohort 1 (Existing NIH Clinical Center Patient/Participants invited to participate by their NIH study team)
* Cohort 2 (Individuals recruited through NIH Occupational Medicine Services (OMS) patients referred by NIH investigators or other providers; individuals who self-refer)
* Located in the United States
* Positive test for SARS-CoV-2 virus infection
* Age greater than or equal to 3 years old

  * only for participants providing a blood sample

EXCLUSION CRITERIA:

* Individuals for whom we cannot consent for participation in a language offered by our existing interpretation service.
* Weight less than 10 kg\*